South America CAR-T Cell Therapy Treatment Market to 2032
Overview
The South America CAR-T Cell Therapy Treatment Market is expected to reach a 56.89 USD Million by 2032 and is projected to grow at a CAGR of 20.09% from 2025 to 2032.
Revenue, 2024 (USD Million)
20.40
Forecast, 2032 (USD Million)
56.89
CAGR, 2024 - 2032
20.09%
Report Coverage
South America
South America CAR-T Cell Therapy Treatment Market 2018-2032 USD Million
South America CAR-T Cell Therapy Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 20.40 USD Million
- Projected Market Size (2032): 56.89 USD Million
- CAGR (2025-2032): 20.09%
Key Findings of South America CAR-T Cell Therapy Treatment Market
- The South America CAR-T Cell Therapy Treatment Market was valued at 20.40 USD Million in 2024.
- The South America CAR-T Cell Therapy Treatment Market is likely to grow at a CAGR of 20.09% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Antigens On Hematologic Malignancies in Targeted Antigens Segment accounted for the largest share of the market with a revenue of 20.40 USD Million
- The fastest growing segment Specialty Clinics in End User Segment grew Fastest with a CAGR of 22.59% during the forecast period from 2024 to 2032.
South America CAR-T Cell Therapy Treatment Market Scope
South America CAR-T Cell Therapy Treatment Market Segmentation & Scope
Targeted Antigens
- Others
- Antigens On Hematologic Malignancies
- Antigens On Solid Tumors
Brand
- Yescarta
- Kymriah
- Tecartus
- Others
Therapeutic Application
- Follicular Lymphoma
- Diffuse Large B-Cell Lymphoma
- Acute Lymphoblastic Leukaemia (ALL)
- Mantle Cell Lymphoma
- Multiple Myeloma
- Hematologic Malignancies
- Lung Cancer
- Chronic Lymphocytic Leukemia
- Gastric Cancer
- Pancreatic Cancer
- Breast Cancer
- Others
Product
- Autologous CAR-T Cells
- Allogeneic CAR-T Cells
Structure
- First Generation CAR-T Cells
- Second Generation CAR-T Cells
- Third Generation CAR-T Cells
- Fourth Generation CAR-T Cells
End User
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Others
South America CAR-T Cell Therapy Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 20.40 USD Million |
| Market Value in 2032 | 56.89 USD Million |
| CAGR (2025-2032) | 20.09% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Targeted Antigens, Brand, Therapeutic Application, Product, Structure, End User, Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): South America, leading in terms of revenue 20.40 USD Million in 2024
- Key Country: Argentina, leading in terms of revenue with value of 3.06 USD Million in 2024.
Segments and Scope
-
South America CAR-T Cell Therapy Treatment Market to 2032, By Targeted Antigens
- Antigens On Hematologic Malignancies is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 20.40 USD Million in the year 2024.
- Antigens On Hematologic Malignancies is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 20.09 % in forecast period 2025-2032.
-
South America CAR-T Cell Therapy Treatment Market to 2032, By Brand
- Kymriah is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 14.17 USD Million in the year 2024.
- Yescarta is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 18.38 % in forecast period 2025-2032.
-
South America CAR-T Cell Therapy Treatment Market to 2032, By Therapeutic Application
- Diffuse Large B-Cell Lymphoma is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 11.90 USD Million in the year 2024.
- Acute Lymphoblastic Leukaemia (ALL) is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 18.37 % in forecast period 2025-2032.
-
South America CAR-T Cell Therapy Treatment Market to 2032, By Product
- Autologous CAR-T Cells is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 20.40 USD Million in the year 2024.
- Autologous CAR-T Cells is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 20.09 % in forecast period 2025-2032.
-
South America CAR-T Cell Therapy Treatment Market to 2032, By Structure
- Second Generation CAR-T Cells is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 20.40 USD Million in the year 2024.
- Second Generation CAR-T Cells is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 20.09 % in forecast period 2025-2032.
-
South America CAR-T Cell Therapy Treatment Market to 2032, By End User
- Hospitals is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 15.70 USD Million in the year 2024.
- Specialty Clinics is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 19.63 % in forecast period 2025-2032.
-
South America CAR-T Cell Therapy Treatment Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 15.70 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in South America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 19.63 % in forecast period 2025-2032.
South America CAR-T Cell Therapy Treatment Market Company Share Analysis
| Company Name |
|
||
| Novartis AG | |||
| Kite Pharma Inc. | |||
South America CAR-T Cell Therapy Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
South America CAR-T Cell Therapy Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South America CAR-T Cell Therapy Treatment Market is segmented based on Segmentation Targeted Antigens, Brand, Therapeutic Application, Product, Structure, End User, Distribution Channel.
South America CAR-T Cell Therapy Treatment Market was valued at USD 20.40(Revenue in USD Million) in 2019.
South America CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 20.09% during the forecast period of 2024 to 2032.
The Antigens On Hematologic Malignancies segment is expected to dominate the South America CAR-T Cell Therapy Treatment Market, holding a largest market share of 20.40 USD Million in 2024
South America CAR-T Cell Therapy Treatment Market Scope
South America CAR-T Cell Therapy Treatment Market Segmentation & Scope
Targeted Antigens
- Others
- Antigens On Hematologic Malignancies
- Antigens On Solid Tumors
Brand
- Yescarta
- Kymriah
- Tecartus
- Others
Therapeutic Application
- Follicular Lymphoma
- Diffuse Large B-Cell Lymphoma
- Acute Lymphoblastic Leukaemia (ALL)
- Mantle Cell Lymphoma
- Multiple Myeloma
- Hematologic Malignancies
- Lung Cancer
- Chronic Lymphocytic Leukemia
- Gastric Cancer
- Pancreatic Cancer
- Breast Cancer
- Others
Product
- Autologous CAR-T Cells
- Allogeneic CAR-T Cells
Structure
- First Generation CAR-T Cells
- Second Generation CAR-T Cells
- Third Generation CAR-T Cells
- Fourth Generation CAR-T Cells
End User
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Others
Frequently Asked Questions
The South America CAR-T Cell Therapy Treatment Market is segmented based on Segmentation Targeted Antigens, Brand, Therapeutic Application, Product, Structure, End User, Distribution Channel.
South America CAR-T Cell Therapy Treatment Market was valued at USD 20.40(Revenue in USD Million) in 2019.
South America CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 20.09% during the forecast period of 2024 to 2032.
The estimated market value of the South America CAR-T Cell Therapy Treatment Market for final year is USD 56.89 (USD Million).
South America CAR-T Cell Therapy Treatment Market Company Profiling
Frequently Asked Questions
The South America CAR-T Cell Therapy Treatment Market is segmented based on Segmentation Targeted Antigens, Brand, Therapeutic Application, Product, Structure, End User, Distribution Channel.
South America CAR-T Cell Therapy Treatment Market was valued at USD 20.40(Revenue in USD Million) in 2019.
South America CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 20.09% during the forecast period of 2024 to 2032.
The estimated market value of the South America CAR-T Cell Therapy Treatment Market for final year is USD 56.89 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.